Form 4 Tracker
TENAX THERAPEUTICS, INC.
TENX

9 insider filings · Latest: Sep 16, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 16, 2026Sep 18 1:30 AMDoogan DeclanDirector
Purchase
53,000$1.92$101.8K55,274(D)

View →

Sep 15, 2026Sep 16 1:38 AMChristopher Thomas GiordanoDirector, CEO
Purchase
4,850$1.82$8.8K22,174(D)

View →

Sep 11, 2026Sep 16 1:38 AMChristopher Thomas GiordanoDirector, CEO
Purchase
6,000$1.88$11.3K17,324(D)

View →

Sep 11, 2026Sep 16 1:30 AMThomas R Staab IIChief Financial Officer
Purchase
5,675$1.94$11.0K15,675(D)

View →

Sep 3, 2026Sep 8 9:16 PMADAR1 Capital Management, LLC10% Owner
Purchase
900,000$1.78$1.6M6,524,151(I)

View →

Sep 2, 2026Sep 2 9:52 PMADAR1 Capital Management, LLC10% Owner
Purchase
187,704$1.80$337.6K5,624,151(I)

View →

Sep 1, 2026Sep 2 9:52 PMADAR1 Capital Management, LLC10% Owner
Purchase
179,058$1.80$321.6K5,436,447(I)

View →

Aug 31, 2026Sep 2 9:52 PMADAR1 Capital Management, LLC10% Owner
Purchase
403,571$1.79$722.6K5,257,389(I)

View →

Aug 24, 2026Aug 24 10:12 PMADAR1 Capital Management, LLC10% Owner
Purchase
107,374$1.75$188.4K4,853,818(I)

View →

Aug 21, 2026Aug 24 10:12 PMADAR1 Capital Management, LLC10% Owner
Purchase
716,369$1.77$1.3M4,746,444(I)

View →

Aug 20, 2026Aug 24 10:12 PMADAR1 Capital Management, LLC10% Owner
Purchase
202,124$1.78$359.5K4,030,075(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 13, 2026Jul 14 11:29 PMChristopher Thomas GiordanoDirector, CEO
Option Exercise
8,719$5.941,241,500(D)

View →

May 11, 2026May 13 9:08 PMThomas R Staab IIChief Financial Officer
Grant/Award
450,000$11.95450,000(D)

View →

Jan 30, 2026Feb 3 10:57 PMThomas McgauleyInterim CFO
Option Exercise
50,000$12.5150,000(D)

View →